Aquestive Therapeutics, Inc. (AQST) Social Stream



Aquestive Therapeutics, Inc. (AQST): $0.95

0.02 (+1.77%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

AQUESTIVE THERAPEUTICS INC (AQST) Price Targets From Analysts

Use the tables below to see what analysts covering AQUESTIVE THERAPEUTICS INC think about its future price and what recommendations they have for investors and traders.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-08 2 $28 $7 $16.333 $0.88 1756.02%
2021-12-23 2 $26 $7 $15.666 $0.88 1680.23%
2022-03-10 2 $14 $7 $9.666 $0.88 998.41%
2022-05-04 2 $14 $8 $11 $0.88 1150%
2022-06-16 2 $8 $8 $8 $0.88 809.09%
2022-07-11 2 $8 $5 $6.5 $0.88 638.64%
2022-08-04 2 $5 $4 $4.5 $0.88 411.36%
2022-08-15 2 $6 $4 $5 $0.88 468.18%
2022-08-30 2 $10 $4 $6.666 $0.88 657.5%
2022-09-06 3 $10 $4 $6.333 $0.88 619.66%
2022-09-28 3 $10 $4 $6.875 $0.88 681.25%
2022-11-02 3 $10 $4 $7.125 $0.88 709.66%
2022-11-04 3 $9.5 $4 $6.375 $0.88 624.43%

The Trend in the Analyst Price Target


AQST's average price target has moved down $4.62 over the prior 29 weeks.

Over the past 45 weeks, AQST's average upside potential has been 517.42%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2022-05-31 2 8.0 8 8.000 0.994 704.83%
2022-06-16 2 8.0 8 8.000 0.727 1000.41%
2022-07-11 2 8.0 5 6.500 0.820 692.68%
2022-09-28 3 10.0 4 7.125 1.160 514.22%
2022-11-04 3 9.5 4 6.375 0.875 628.57%

AQST Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1 3 0 0 0 0 3

The Trend in the Broker Recommendations


Over the past 31 weeks, AQST's average broker recommendation rating improved by 0.

The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for AQST as an investment opportunity.

  • To contextualize these metrics, consider that out of all US stocks, AQUESTIVE THERAPEUTICS INC's number of analysts covering the stock is higher than 70.46% of them.
  • In terms of how AQUESTIVE THERAPEUTICS INC fares relative to all US stocks, note that its upside potential (average analyst target price relative to current price) is greater than 1227.5% of that group.
  • AQUESTIVE THERAPEUTICS INC's average analyst price target is higher than 111.65% of all US stocks.
  • To contextualize these metrics, consider that out of stocks in the small market cap category, AQUESTIVE THERAPEUTICS INC's variance in analysts' estimates is lower than -766.08% of them.

Stocks similar to AQUESTIVE THERAPEUTICS INC in the Pharmaceutical Products industry regarding analyst recommendations and price targets are XERS, KNSA, and EOLS.

Is AQST a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.6243 seconds.